Valeant Has Big Plans To Become A Big Pharma In Coming Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The Canadian specialty pharma has been buying up companies left and right and has plans to continue in 2014, even possibly pursuing a merger of equals in an effort to more than double its market capitalization.